Popular Trials
Kinase Inhibitor
Lapatinib + Herceptin for Metastatic Breast Cancer
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is testing the effects of combining lapatinib with Herceptin for treating breast cancer that has spread outside the breast. They are also investigating if PET/CT scans could predict who would benefit from the treatment and studying genes and proteins in the tumor tissue that could make the cancer sensitive or resistant to Herceptin and the combination of Herceptin with lapatinib.
Tyrosine Kinase Inhibitor
Lapatinib Before Surgery for Brain Tumor
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing how well lapatinib ditosylate works in treating patients with high-grade glioma that has come back. Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Popular Filters
Trials With No Placebo
Protein Kinase Inhibitor
Dabrafenib + Lapatinib for Thyroid Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing the combination of lapatinib and dabrafenib in patients with hard-to-treat thyroid cancer. The drugs work by blocking proteins that help cancer cells grow. The goal is to find the best dose and observe any anti-tumor activity. Dabrafenib has shown antitumor activity in various cancers, including thyroid cancer, and lapatinib is a tyrosine kinase inhibitor used in breast cancer treatment.
Protein Kinase Inhibitor
Targeted Therapy for Lung Cancer
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing whether it is possible to analyze the genes of patients with lung cancer and cancers of the thymus in order to provide personalized treatment with drugs that target the specific gene abnormalities.
Small Molecule Kinase Inhibitor
Lapatinib + Trastuzumab for Breast Cancer
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial demonstrates that targeted therapies can be very successful in reducing tumor recurrences and mortality in early breast cancer. However, there is still a need for new strategies to overcome resistance to these treatments.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.